Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3DIcon Corporation was a developer of advanced volumetric 3D display technologies, primarily focused on the C-360 system which enabled 360-degree, glasses-free 3D visualization. The company's primary value proposition in the healthcare sector was the enhancement of medical imaging, providing radiologists and surgeons with the ability to view MRI and CT data in a true three-dimensional environment. This technology was intended to improve the precision of diagnoses and the planning of complex surgical procedures by allowing for better spatial understanding of anatomical structures. Beyond healthcare, the company explored applications in defense, security, and industrial design. In September 2016, 3DIcon completed a reverse merger with Coretec Industries, resulting in the formation of The Coretec Group. Following the merger, the corporate focus shifted toward advanced silicon-based materials, although the company retained its legacy imaging intellectual property.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3DIcon.